References
- Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52:e103–e120.
- ECDC. Antimicrobial resistance surveillance in Europe 2014. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). 2015.
- Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis. 2003;36:S11–S23.
- Lee SS, Kim Y, Chung DR. Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis. J Infect. 2011;62:159–164.
- Mac Vane SH, Tuttle LO, Nicolau DP. Impact of extended-spectrum β-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. J Hosp Med. 2014;9:232–238.
- Ferrer R, Martin-Loeches I, Phillips G, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42:1749–1755.
- Paul M, Shani V, Muchtar E, et al. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother. 2010;54:4851–4863.
- Moehring RW, Sloane R, Chen LF, et al. Delays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital study. PLoS One. 2013;8:e76225.
- Renvoise A, Decre D, Amarsy-Guerle R, et al. Evaluation of the βLacta test, a rapid test detecting resistance to third-generation cephalosporins in clinical strains of Enterobacteriaceae. J Clin Microbiol. 2013;51:4012–4017.
- Gallah S, Decre D, Genel N, et al. The β-Lacta test for direct detection of extended-spectrum-β-lactamase-producing Enterobacteriaceae in urine. J Clin Microbiol. 2014;52:3792–3794.
- ESCMID. EUCAST-Break point tables for interpretation of MICs and zone diameters, version 4.0. 2014. Available from: URL:http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/Breakpoint_table_v_4.0.pdf.
- Bille E, Dauphin B, Leto J, et al. MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures. Clin Microbiol Infect. 2012;18:1117–1125.
- Bonnet R, Caron F, Cavallo JD, et al. Comité de l'antibiogramme de la Société Française de Microbiologie. Recommandations. 2013.
- Hanaki H, Koide Y, Yamazaki H, et al. Substrate specificity of HMRZ-86 for beta-lactamases, including extended-spectrum beta-lactamases (ESBLs). J Infect Chemother. 2007;13:390–395.
- Laurent T, Huang TD, Bogaerts P, et al. Evaluation of the beta-LACTA test, a novel commercial chromogenic test for rapid detection of ceftazidime-nonsusceptible Pseudomonas aeruginosa isolates. J Clin Microbiol. 2013;51:1951–1954.